Oricell Therapeutics to Showcase Innovations in Cell Therapies for oncology at 42nd JP Morgan Healthcare Conference
Oricell Therapeutics Co., Ltd.
Committed to Developing Novel Immunotherapies
Shanghai, China, and New Jersey, USA – January 1, 2024: Oricell Therapeutics (“Oricell” or the "Company"), a global clinical-stage biopharmaceutical firm dedicated to innovative cell therapies for oncology, is set to make its presence felt at the 42nd Annual JP Morgan Healthcare Conference. Co-founder and Chief Executive Officer, Ms. Helen Yang, and co-founder and Chief Scientific Officer, Dr. Peter He, will jointly participate in the conference.
During the event, we will share insights on the company's latest advancements in the field.
Presentation Date: January 10, 2024.
Presentation Time: 4:00 pm - 4:25 pm Pacific time.
Presentation Venue: San Francisco Marriott Marquis Golden Gate.